08:00 – 08:10 |
Welcome & Opening Remarks
Rafael S. Andrade, MD, MHA, Minneapolis, MN, USA
|
08:10 – 10:00 |
General Session 1: Advances in Immunotherapy and Targeted Therapy for Lung Cancer
Fernando Vannucci, MD, Rio de Janeiro, Brazil; Rafael S. Andrade, MD, MHA, Minneapolis, MN, USA
- Immunotherapy for Operable NSCLC - Review of Evidence
Patrick Forde, MBBCh, Baltimore, MD, USA
- Neoadjuvant vs Adjuvant Immunotherapy - Debate
Clarissa Baldotto, MD, PhD, Rio de Janeiro, Brazil (pre); Patrick Forde, MBBCh, Baltimore, MD, USA (post)
- Targeted Therapy for Operable NSCLC
Mara B. Antonoff, MD, Houston, TX, USA
- Outcomes and Survival followed Wedge Resection Versus Lobectomy for Early-Stage Non-Small Cell Lung Cancer: A
Propensity Score-Matched Analysis in a First Peruvian RegistryA
Wildor Samir Cubas Llalle, MD, MSc, Lima, Perú
- Hospital-Based Cancer Registries: Validating Methodological Approaches to Adjust Lung Cancer Staging in BrazilA
Isabel Emmerick, PhD, Worcester, MA, USA
- Discussion
|
10:00 – 10:30 |
Break/Visit Exhibits
|
10:30 – 13:05 |
General Session 2: Lung Cancer Surgery: When and How
Jose J. Camargo, MD, Porto Alegre, Brazil; Nuria M. Novoa, MD, PhD, FEBTS, Salamanca, Spain
- Stage III NSCLC – Surgery vs Non-Surgical Treatment - Debate
Sergio Bolufer Nadal, MD, PhD, Alicante, Spain; Enrique Guzmán De Alba, MD, Mexico City, Mexico
- Lymph Node Management – Sampling or Complete Dissection?
Enrique Guzmán De Alba, MD, Mexico City, Mexico
- Lobectomy vs Sublobar Resection for NSCLC - Debate
Alessandro Brunelli, MD, Leeds, UK; Ricardo M. Terra, MD, MPH, PhD, São Paulo, Brazil
- Economical and Sustainable VATS Lobectomy
Artur Gomes Neto, MD, Maceio-AL, Brazil
- Transareolar Incision Applied in Video-assisted Thoracoscopic Surgery of the Right Middle LobectomyA
Zhangfan Mao, MD, Wuhan, China
- Outcomes of Robotic Assisted Thoracic Surgery versus Video Assisted Thoracic Surgery in Mexico. Focus on ComplicationsA
Gildardo Cortes Julian, MD, Guadalajara, Mexico
- Discussion
|
13:05 – 14:15 |
Break/Visit Exhibits
|
14:15 – 15:50 |
General Session 3: Minimally Invasive Lung Resection: What is Best?
Flávio Brito Filho, MD, Brasília, Brazil; Richard S. Milton, FRCS (CTh), Leeds, UK
- VATS vs RATS Lobectomy - Debate
Marion Durand, MD, PhD, Neuilly Sur Seine, France; Darcy Ribeira Pinto Filho, MD, Caxias do Sul, Brazil
- VATS/RATS Lobectomy - Intraoperative Management of Life-Threatening Complications
John D. Mitchell, MD, Aurora, CO, USA
- Management of Complications Following Lung Cancer Resection
Nuria M. Novoa, MD, PhD, FEBTS, Salamanca, Spain
- Early Experience in Uniportal VATS SegmentectomiesA
José Miguel Clavero, MD, Santiago, Chile
- Post-Operative Pain and Quality of Life in Video-Assisted Versus Robot-Assisted Thoracoscopic Surgery: A Prospective Cohort Study at a Single High-Volume InstitutionA
Stephen C. Yang, MD, FACS, MAMSE, Baltimore, MD
- Discussion
|
15:50 – 16:20 |
Break/Visit Exhibit
|
16:20 – 17:45 |
General Session 4: Update on Thymic Tumors and Challenges in Lung Cancer Surgery
Carlos Alberto Almeida Araújo, MD, Natal, Brazil; Enrique Guzmán De Alba, MD, Mexico City, Mexico
- Management of Thymic Tumors – Surgery and Perioperative Therapy
Enrico Ruffini, MD, Torino, Italy
- Status of Lung Cancer Surgery in Latin America – Opportunities and Challenges
Luis Fernando Rueda Marulanda, MD, Barranquilla, Colombia
- Oligometastatic Disease
José Miguel Clavero, MD, Santiago, Chile
- Lung Cancer Demographic Profile and Treatment in Public and Private Healthcare Sectors: Data from the Brazilian Lung Cancer RegistryA
Juliana Vieira de Oliveira Salerno, Brazil
- 5-year Survival of 48 Cases of Thymoma Surgical Resections in a Single Thoracic Surgery ServiceA
Anna Maria Garcia Cardoso, Brazil
- Discussion
|
17:45 – 17:50 |
Closing Remarks
Rafael S. Andrade, MD, MHA, Minneapolis, MN, USA
|